| Literature DB >> 35733362 |
Marie-Noëlle Billard1, Peter M van de Ven2, Bianca Baraldi1,3, Leyla Kragten-Tabatabaie4,5, Louis J Bont5, Joanne G Wildenbeest1.
Abstract
BACKGROUND: Little RSV activity was observed during the first expected RSV season since the COVID-19 pandemic. Multiple countries later experienced out-of-season RSV resurgences, yet their association with non-pharmaceutical interventions (NPIs) is unclear. This study aimed to describe the changes in RSV epidemiology during the COVID-19 pandemic and to estimate the association between individual NPIs and the RSV resurgences.Entities:
Keywords: COVID-19; RSV; SARS-COV2; non-pharmaceutical interventions; seasonality
Mesh:
Year: 2022 PMID: 35733362 PMCID: PMC9343326 DOI: 10.1111/irv.12998
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 5.606
FIGURE 1Flowchart of country selection
Characteristics of the pre‐pandemic RSV season and first pandemic RSV season, changes in RSV epidemiology, per country
| South Africa | Brazil | Chile | France | The Netherlands | Israel | The United States | Canada | Japan | Taiwan | South Korea | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| First RSV epidemic during COVID‐19 pandemic | |||||||||||
| Expected epidemic period | |||||||||||
| Onset week | W06‐2020 | W09‐2020 | W24‐2020 | W47‐2020 | W48‐2020 | W49‐2020 | W48‐2020 | W50‐2020 | W27‐2020 | W21‐2020 | W42‐2020 |
| Peak week | W10‐2020 | W14‐2020 | W34‐2020 | W50‐2020 | W01‐2021 | W52‐2020 | W01‐2021 | W04‐2021 | W36‐2020 | W32‐2020 | W48‐2020 |
| Offset week | W22‐2020 | W28‐2020 | W28‐2020 | W05‐2021 | W07‐2021 | W05‐2021 | W10‐2021 | W12‐2021 | W50‐2020 | W42‐2020 | W07‐2021 |
| Observed epidemic period | |||||||||||
| Onset week | W35‐2020 | W44‐2021 | W33‐2021 | W07‐2021 | W22‐2021 | W25‐2021 | W27‐2021 | W39‐2021 | W21‐2021 | W41‐2020 | ‐ |
| Peak week | W40‐2020 | ‐ | W43‐2021 | W11‐2021 | W29‐2021 | W30‐2021 | W35‐2021 | ‐ | W28‐2021 | W45‐2020 | ‐ |
| Offset week | W42‐2020 | ‐ | ‐ | W17‐2021 | W44‐2021 | W35‐2021 | W42‐2021 | ‐ | W34‐2021 | W02‐2020 | ‐ |
| Second RSV epidemic period during COVID‐10 pandemic | |||||||||||
| Onset week | W46‐2020 | ‐ | W44‐2021 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | |
| Peak week | W10‐2021 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Offset week | W11‐2021 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Delay of first RSV epidemic during COVID‐19 pandemic | |||||||||||
| Delayed/missed season | Delayed | Missed | Missed | Delayed | Delayed | Delayed | Delayed | Missed | Missed | Delayed | Missed |
| Onset delay (weeks) | 29 | 88 | 62 | 13 | 27 | 29 | 32 | 42 | 47 | 20 | ‐ |
| Peak delay (weeks) | 30 | ‐ | ‐ | 14 | 28 | 31 | 34 | ‐ | 45 | 13 | ‐ |
| Season of RSV epidemic onset | |||||||||||
| Pre‐pandemic RSV seasons | Summer | Summer | Winter | Autumn | Winter | Winter | Winter | Winter | Summer | Summer | Autumn |
| First RSV epidemic during COVID‐19 pandemic | Winter | Winter | Winter | Winter | Summer | Summer | Summer | Autumn | Spring | Winter | ‐ |
The meteorological seasons were defined as follows. For France, the Netherlands, the United States, Canada, Japan, and South Korea: spring from March to May, summer from June to August, autumn from September to November and winter from December to February. For South Africa and Chile: spring from September to November, summer from December to February, autumn from March to May and winter from June to August. For Israel and Taiwan: summer from May to September and winter from October to April. For Brazil: summer from October to April, winter from May to September.
FIGURE 2Changes in non‐pharmaceutical interventions, weekly proportions of RSV detections and RSV epidemics from W11–2020 to W44–2021 and in pre‐pandemic seasons, in 11 countries
Non‐pharmaceutical interventions that were downgraded in the 10 weeks preceding the start of the RSV resurgence (for week >0.5% RSV detections) and number of weeks between changes in NPIs and the peak of the first RSV epidemic during the COVID‐19 pandemic
| South Africa | Brazil | Chile | France | The Netherlands | Israel | The United States | Canada | Japan | Taiwan | South Korea | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Start of the RSV increase | W27‐2020 | W40‐2021 | W20‐2021 | W47‐2020 | W11‐2021 | W17‐2021 | W12‐2021 | W28‐2021 | W01‐2021 | W32‐2020 | ‐ |
| Peak week first RSV epidemic during COVID‐19 | W40‐2020 | ‐ | W43‐2021 | W11‐2021 | W29‐2021 | W30‐2021 | W35‐2021 | ‐ | W28‐2021 | W45‐2020 | ‐ |
| Time from downgrading NPIs to RSV peak (weeks) | |||||||||||
| School closures | 16 | 25 | 23 | 23 | 14 | 29 | |||||
| Workplace closures | 21 | 19 | 21 | ||||||||
| Stay‐at‐home requirements | 17 | 21 | 25 | ||||||||
| Gatherings restrictions | 25 | 20 | |||||||||
| Public events cancellation | 21 | 28 | |||||||||
| Facemasks policy | 14 | 32 | |||||||||
| Public transport closures | |||||||||||
| Restriction internal movements | 21 | 21 | |||||||||
| International travel controls | 19 | ||||||||||
Association between non‐pharmaceutical interventions stringency levels and changes in RSV activity during the pandemic, defined as the difference between expected and observed proportions of weekly RSV detections, in linear mixed models, including hemisphere and country as random effects
| Univariate models | Full model | Final model | Proportion of variance explained | ||||
|---|---|---|---|---|---|---|---|
| Coeff |
| Coeff |
| Coeff |
| ||
|
| |||||||
| Stringency index (per 1 point) |
|
| ‐ | ‐ | ‐ | ‐ |
|
|
| |||||||
| School closures |
|
|
|
|
|
|
|
| Stay‐at‐home requirements |
|
| −1.69 | 0.19 |
|
|
|
| Restriction internal movements |
|
| −0.64 | 0.38 | ‐ | ‐ | ‐ |
| Public transport closures |
|
| −1.07 | 0.25 | ‐ | ‐ | ‐ |
| Gatherings restrictions | −1.10 | 0.20 | −0.21 | 0.83 | ‐ | ‐ | ‐ |
| Public events cancellation | −0.70 | 0.47 | 0.26 | 0.81 | ‐ | ‐ | ‐ |
| Workplace closures | −0.27 | 0.68 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Facemasks policy | 0.07 | 0.99 | ‐ | ‐ | ‐ | ‐ | ‐ |
| International travel controls | 0.003 | 0.99 | ‐ | ‐ | ‐ | ‐ | ‐ |
|
| |||||||
| School closures |
|
| −1.64 | 0.20 |
|
|
|
| Stay‐at‐home requirements | −1.07 | 0.29 | −0.50 | 0.07 | ‐ | ‐ | ‐ |
| Restriction internal movements |
|
| −1.45 | 0.63 | ‐ | ‐ |
|
| Public transport closures |
|
| −1.50 | 0.21 |
|
|
|
| Gatherings restrictions | −0.38 | 0.70 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Public events cancellation | −0.87 | 0.38 | −0.18 | 0.86 | ‐ | ‐ | ‐ |
| Workplace closures | −0.10 | 0.91 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Facemasks policy | 0.04 | 0.98 | ‐ | ‐ | ‐ | ‐ | ‐ |
| International travel controls | 0.35 | 0.79 | ‐ | ‐ | ‐ | ‐ | ‐ |
R2 calculated with Nakagawa and Schielzeth approach.
Note: Values in bold refer to variable that were statistically significant (p < 0.1) as per the methods.